Researchers from Johns Hopkins University have identified three subtypes of senescent skin cells with distinct shapes, ...

Senescent skin cells, often referred to as zombie cells because they have outlived their usefulness without ever quite dying, ...

A study by former Junior Associate Professor Kazuo Takayama, currently a professor of the Institute of Science Tokyo, ...

Cold' tumors are resistant to common immunotherapies. Researchers have uncovered a master regulator that can be manipulated to prevent tumor growth in mice.

Researchers have identified a compound that could block certain life-threatening and hard-to-treat allergic reactions.

Researchers have developed a new therapy that can be injected intravenously right after a heart attack to promote healing and prevent heart failure. The therapy both prompts the immune system to ...

Groundbreaking treatment enhances the immune system’s ability to fight cancer Holy Cross Health now offers bispecific therapy, an innovative class of antibody drugs providing new hope for patients ...

An experimental vaccine for acne could someday transform the way patients with the condition are treated, according to the ...

Researchers from The University of Texas MD Anderson Cancer Center will present promising results from clinical trials in ...

Technology Networks spoke with Dr. Jenny Bailey Cooper, co-founder and CEO of Ferryx, to learn the science behind its lead ...

Incyte (Nasdaq:INCY) today announced that the Company will present new early-stage data from its oncology portfolio at the American Association of Cancer Research (AACR) Annual Meeting 2025 in Chicago ...